http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104710428-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6be63a2b719c6019932a8a2c3cf19fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02fdbc50f5e80b81fd9fb39a3bac423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20811e92c2d48d53b0461ae93f27d519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6644b824d075e0a4e357f7d21df1401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e7944737832b13929510e30471709a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e2f766383bcdef5a9524039867c39ee
publicationDate 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104710428-A
titleOfInvention Benzoxazole kinase inhibitors and methods of use
abstract The present invention provides chemical entities or compounds capable of modulating protein kinases such as mTor, tyrosine kinases and/or lipid kinases such as PI3 kinase and pharmaceutical compositions thereof. The invention also provides methods of modulating the activity of one or more of these kinases using these compositions, particularly for therapeutic applications.
priorityDate 2008-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007293516-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007079164-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007112005-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468290723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163712481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467455538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465698642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465222962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467080175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID351840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415726320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57675156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466857939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420980306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465372913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467562723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163936702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467724211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466717951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467557576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468306529

Total number of triples: 54.